Evidence map›Paper›PMID 39161120›Full record

ArticleESC heart failure2024

The role of maximal inspiratory pressure on functional performance in adults with heart failure.

Rohan V Shah, Lawrence P Cahalin, Jacob M Haus, Kelly Allsup, Amanda Delligatti, Cody Wolf, Erica R Checko Scioli, Jayashri R Aragam, Daniel J Gottlieb, Thomas D Byard and 1 more

Abstract read
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rohan V ShahCarolinas Hospitalist Group, Atrium Health, Charlotte, North Carolina, USA.
Lawrence P CahalinDepartment of Physical Therapy, University of Miami Miller School of Medicine, Coral Gables, Florida, USA.
Jacob M HausSchool of Kinesiology, University of Michigan, Ann Arbor, Michigan, USA.
Kelly AllsupUnaffiliated.
Amanda DelligattiVA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
Cody WolfVA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
Erica R Checko ScioliVA Boston Healthcare System, Boston, Massachusetts, USA.
Jayashri R AragamVA Boston Healthcare System, Boston, Massachusetts, USA.
Daniel J GottliebVA Boston Healthcare System, Boston, Massachusetts, USA.
Thomas D ByardVA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
Daniel E FormanVA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-5697-2189

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Exploring regulatory mechanisms of glyoxalase-1R21AG081916 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAUS, JACOB M · 2023 to 2024
$429k
NIA NIH HHS R21 AG081916NIDDK NIH HHS P30 DK020572U.S. Department of Veterans Affairs VA RR&D F0834-R
6 · The paper itself

Abstract

backgroundExercise intolerance is common among adults with heart failure (HF) and is a strong prognostic indicator. We examined maximal inspiratory pressure (MIP) as an indicator of maximal and submaximal exercise capacity in older HF patients.

methodsFifty-one patients age ≥ 50 years with HF underwent MIP testing via the PrO

resultsThe median age was 69 years [interquartile range (IQR): 66-73], and the median LVEF was 36.5% (IQR: 30%-45%). Regression identified MIP as an independent predictor for grip strength, 6MWD, 1RM weight and 30 s STS after adjustment for age, BMI and LVEF. MIP greater than the median (n = 25) independently predicted and reflected greater peak VO

conclusionThe analysis demonstrates that MIP is a novel biometric for exercise tolerance in adults with HF. Assessments of MIP are safe and convenient, with the potential to enhance routine HF surveillance and provide novel biometrics to guide HF therapeutics.

Indexed as

Exercise ToleranceHeart FailureMaximal Respiratory PressuresStroke VolumeAgedExercise TestFemaleHumansMaleMiddle AgedMuscle StrengthOxygen ConsumptionPrognosisVentricular Function, Leftexercise intolerancefunctional assessmentheart failureinspiratory muscle performancemaximal inspiratory pressureremote

Identifiers

PMID39161120
PMCPMC11631305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.